Drugs / Autologous serum

Trials 9

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials · 1 met primary
Phase 2 NCT07014059 Jun 2025 → Jun 2026 overdue Sjogren syndrome, Stevens-Johnson syndrome, corneal ulcer, graft versus host disease +2 GIANCARLO FATOBENE Not yet recruiting No outcome recorded
Phase 2 NCT00779987 Oct → Dec 2008 dry eye syndrome University of Chile Completed Met primary
Phase 31 trial
Phase 3 NCT05598242 Feb → Sep 2019 Sjogren syndrome, dry eye syndrome Hospital Nacional Profesor Alejandro Posadas Completed No outcome recorded
Phase 42 trials
Phase 4 NCT03608761 Feb → Oct 2017 Sjogren syndrome, dry eye syndrome Hospital Nacional Profesor Alejandro Posadas Completed No outcome recorded
Phase 4 NCT02752763 Oct 2015 → Mar 2016 dry eye syndrome Niğde State Hospital Completed No outcome recorded
Phase not applicable4 trials
— NCT02291731 Sep 2014 → Aug 2015 corneal disorder E-DA Hospital Completed No outcome recorded
— NCT02147509 Mar 2013 → Apr 2014 Sjogren syndrome Jinyang Li Completed No outcome recorded
— NCT00238862 Oct 2005 → Sep 2006 corneal disorder King Khaled Eye Specialist Hospital Completed No outcome recorded
— NCT00442273 — dry eye syndrome Chonnam National University Hospital Completed No outcome recorded
Comparator or background therapy6 trials
Phase 1 NCT05331859 Comparator May → Aug 2022 corneal disorder Benha University Unknown No outcome recorded
Phase 1/2 NCT07551843 Comparator Oct 2023 → Dec 2024 dry eye syndrome G.Gennimatas General Hospital Completed No outcome recorded
Phase 3 NCT04683796 Comparator Feb 2021 → Feb 2023 dry eye syndrome Mahidol University Completed Met primary
Phase 3 NCT03436576 Comparator Sep → Oct 2018 Sjogren syndrome, dry eye syndrome Pontificia Universidad Catolica de Chile Unknown No outcome recorded
Phase 4 NCT03666884 Comparator Oct 2015 → Mar 2016 dry eye syndrome Seref istek Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 15 sources stand behind the page.

FieldValueCited text
Known as Autologous Serum “AIM: To evaluate the efficacy of autologous serum application for the treatment of dry eye in Sjögren's syndrome.” PMID 10434857 ↗ Apr 1999
14

“autologous serum eye drops (ASED)” NCT05598242 ↗

“AS: Autologous Serum” NCT02147509 ↗

NCT05944757 ↗

NCT04683796 ↗

NCT00238862 ↗

NCT02291731 ↗

NCT03608761 ↗

NCT03436576 ↗

NCT00779987 ↗

NCT00442273 ↗

Show 4 more sources

Known as ASED “Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases;” NCT07014059 ↗
1

“autologous serum eye drops (ASED)” NCT05598242 ↗

Route Topical “Autologous serum eyedrops” NCT00442273 ↗